International Journal of Drug Policy
Volume 21, Issue 6 , Pages 459-465 , November 2010

Managing la malilla: Exploring drug treatment experiences among injection drug users in Tijuana, Mexico, and their implications for drug law reform

  • Jennifer Syvertsen

      Affiliations

    • Department of Anthropology, University of South Florida, United States
    • Division of Global Public Health, Department of Medicine, University of California San Diego, United States
    • ,
  • Robin A. Pollini

      Affiliations

    • Division of Global Public Health, Department of Medicine, University of California San Diego, United States
    • Corresponding Author InformationCorresponding author at: Division of Global Public Health, Department of Medicine, University of California San Diego, Department of Medicine, 9500 Gilman Drive, MC 0507, La Jolla, CA 92093-0507, United States. Tel.: +1 858 534 0710; fax: +1 858 534 7566.
    • ,
  • Remedios Lozada

      Affiliations

    • Pro-COMUSIDA, Tijuana, Mexico
    • ,
  • Alicia Vera

      Affiliations

    • Division of Global Public Health, Department of Medicine, University of California San Diego, United States
    • ,
  • Gudelia Rangel

      Affiliations

    • Division of Global Public Health, Department of Medicine, University of California San Diego, United States
    • El Colegio de la Frontera del Norte, Tijuana, Mexico
    • ,
  • Steffanie A. Strathdee

      Affiliations

    • Division of Global Public Health, Department of Medicine, University of California San Diego, United States

Received 15 April 2010 ,Revised 25 June 2010 ,Accepted 28 June 2010.

References 

  1. Agar MH. Folks and professionals: Different models for the interpretation of drug use. Substance Use & Misuse. 1985;20(1):173–182
  2. Agar MH, Stephens RC. The methadone street scene: The addict's view. Psychiatry. 1975;38(4):381
  3. ATLAS.ti. (2007). ATLAS.ti Scientific Software Development.
  4. Bolanos, C. (2009). Rescata la PGJ a 107 “esclavos”. El Universal. Available from http://www.eluniversal.com.mx/ciudad/98949.html. Accessed 28.04.10.
  5. Bourgois P. Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry. 2000;24:165–195
  6. Brouwer KC, Case P, Ramos R, Magis-Rodríguez C, Bucardo J, Patterson TL, et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Substance Use & Misuse. 2006;41(5):707–727
  7. Bucardo J, Brouwer KC, Magis-Rodríguez C, Ramos R, Fraga M, Perez SG, et al. Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections. Drug and Alcohol Dependence. 2005;79(3):281–293
  8. Bustamante-Moreno, J. G., Izazola-Licea, J. A., & Rodriguez-Ajenjo, C. (in press). Tackling HIV and drug addiction in Mexico. Lancet.
  9. COFEPRIS. (2004). Desalojan Centros de rehabilitacion Clandestinos. Available from http://www.cofepris.gob.mx/work/sites/cfp/resources/LocalContent/395/3/b4.pdf. Accessed 28.04.10.
  10. Cohen JE, Amon JJ. Health and human rights concerns of drug users in detention in Guangxi Province, China. PLoS Medicine. 2008;5(12):e234
  11. Consejo Nacional contra las Adicciones (CONADIC). (n.d.). Guia para la aplicacion de la NOM-028-SSA2-1999, para la Prevencion, Tratamiento y Control de las Adicciones.
  12. Cruz, N. (2009). Mayoría de Centros de rehabilitación explotan a los adictos. El Sol de Tijuana. Available from http://www.oem.com.mx/esto/notas/n1040499.htm. Accessed 10.04.10.
  13. Dibble, S., & Cearley, A. (2004). Questions swirl around closure of teen centers: Mexican officials, school staff under scrutiny since raids. San Diego Union Tribune. Available from http://legacy.signonsandiego.com/uniontrib/20040919/news_20040911n20040919raid.html. Accessed 10.04.10.
  14. Fraser J. Methadone clinic culture: The everyday realities of female methadone clients. Qualitative Health Research. 1997;7(1):121
  15. Frost SDW, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, et al. Respondent-driven sampling of injection drug users in two US–Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health. 2006;83:83–97
  16. Goldsmith DS, Hunt DE, Lipton DS, Strug DL. Methadone folklore: Beliefs about side effects and their impact on treatment. Human Organization. 1984;43(4):330–340
  17. Grillo, I. (2009). Mexico's new drug law may set an example. Time. Available from http://www.time.com/time/world/article/0%2C8599%2C1918725%2C00.html. Accessed 10.04.10.
  18. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports. 1998;113:107–115
  19. Heckathorn DD. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems. 1997;174–199
  20. Hernández Ávila M, Rangel Gómez G, Ruiz y Ávila EB. Condiciones de salud en la frontera norte de México. Mexico City: Comisión de Salud Fronteriza México-Estados Unidos, Instituto Nacional de Salud Pública, El Colegio de la Frontera; 2008;
  21. Human Rights Watch . Skin on the cable: The illegal arrest, arbitrary detention, and torture of people who use drugs in Cambodia. New York: Human Rights Watch; 2010;
  22. Inaba DS, Gay GR, Whitehead CA, Newmeyer JA, Bergin D. The use of propoxyphene napsylate in the treatment of heroin and methadone addiction. Western Journal of Medicine. 1974;121(2):106
  23. INEGI. (2005). XII Censo General de Poblacion y Vivienda.
  24. Iniguez-Stevens E, Brouwer KC, Hogg RS, Patterson TL, Lozada R, Magis-Rodriguez C, et al. Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico. Gaceta Medica de Mexico. 2009;145(3):189
  25. Instituto de Psiquiatria del Estado de Baja California. Centros de Rehabilitacion, n.d. Available from http://www.ipebc.gob.mx/main.php?id_cont=61&id_pagina=47. Accessed 01.04.10.
  26. Instituto Nacional de Salud Pública . Encuesta Nacional de Adicciones 2008. Cuernavaca, Morelos, Mexico: Instituto Nacional de Salud Pública; 2008;
  27. International Harm Reduction Development Program . Human rights abuses in the name of drug treatment: Reports from the field. New York: Open Society Institute; 2009;
  28. Klag S, O’Callaghan F, Creed P. The use of legal coercion in the treatment of substance abusers: A an overview and critical analysis of thirty years of research. Substance Use & Misuse. 2005;40(12):1777–1795
  29. Koester S. The disconnect between China's public health and public security responses to injection drug use, and the consequences for human rights. PLoS Medicine. 2008;5(12):e240
  30. Koester S, Anderson K, Hoffer L. Active heroin injectors’ perceptions and use of methadone maintenance treatment: Cynical performance or self-prescribed risk reduction?. Substance Use & Misuse. 1999;34(14):2135–2153
  31. Lacey, M. (2009). In Mexico, ambivalence on a drug law. New York Times. Available from http://www.nytimes.com/2009/08/24/world/americas/24mexico.html?pagewanted=1&hp. Accessed 10.06.10.
  32. Lynn ES, David SM, Paul JF, David AF. Decreasing international HIV transmission: The role of expanding access to opioid agonist therapies for injection drug users. Addiction. 2005;100(2):150–158
  33. Magis-Rodriguez C, Bravo Garcia E, Gayet Serrano C, Rivera Reyes P, De Luca M. El VIH y el SIDA en Mexico al 2008: Hallazgos, tendencias y reflexiones. Mexico City: Centro Nacional para la Prevencion y Control del VIH/SIDA (CENSIDA); 2008;
  34. Magis-Rodriguez C, Brouwer KC, Morales S, Gayet C, Lozada R, Ortiz-Mondragon R, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican–U.S. border city of Tijuana. Journal of Psychoactive Drugs. 2005;37(3):333–339
  35. Magis-Rodriguez C, Marques LF, Touze G. HIV and injection drug use in Latin America. AIDS. 2002;16(Suppl. 3):34–41
  36. Mayhew S, Collumbien M, Qureshi A, Platt L, Rafiq N, Faisel A, et al. Protecting the unprotected: Mixed-method research on drug use, sex work and rights in Pakistan's fight against HIV/AIDS. British Medical Journal. 2009;85(Suppl. 2):ii31–ii36
  37. National Drug Intelligence Center . California Border Alliance Group drug market analysis 2009. Washington, DC: National Drug Intelligence Center, U.S. Department of Justice; 2009;
  38. Nichter M, Quintero G, Nichter M, Mock J, Shakib S. Qualitative research: Contributions to the study of drug use, drug abuse, and drug use(r)-related interventions. Substance Use & Misuse. 2004;39(10–12):1907–1969
  39. NOM-028. (2009). Modificación a la Norma Oficial Mexicana NOM-028-SSA2-1999, Para la prevención, tratamiento y control de las adicciones, para quedar como Norma Oficial Mexicana NOM-028-SSA2-2009, Para la prevención, tratamiento y control de las adicciones. Mexico City, Mexico.
  40. Pollini RA, Brouwer KC, Lozada RM, Ramos R, Cruz MF, Magis-Rodriguez C, et al. Syringe possession arrests are associated with receptive syringe sharing in two Mexico–US border cities. Addiction. 2008;103(1):101
  41. Salazar, E. (2009). Sin certificar, 70% de centros de rehabilitación en México. Noticieros Televisa. Available from http://www2.esmas.com/noticierostelevisa/mexico/nacional/101858/sin-certificar-70-centros-rehabilitacion-mexico. Accessed 10.06.10.
  42. SAS. (2009). Version 9.2. Cary, NC.
  43. Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M. A 12-year follow-up of a methadone medical maintenance program. American Journal on Addictions. 1999;8(4):293–299
  44. Secretaria de Salud de Baja California . Observatorio Estatal de las Adicciones, 2009: Baja California. Mexicali, B.C.: Secretaria de Salud de Baja California; 2009;
  45. Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. Journal of Acquired Immune Deficiency Syndromes. 2008;47(3):369
  46. Wagner, H. (2010). Pagarán becas para rehabilitar a adictos. Diario de Querétaro. Available from http://www.oem.com.mx/diariodequeretaro/notas/n1674089.htm. Accessed 22.06.10.
  47. Watters J, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems. 1989;36:416–430
  48. Wolfe D, Saucier R. In rehabilitation's name? Ending institutionalised cruelty and degrading treatment of people who use drugs. International Journal of Drug Policy. 2010;21(3):145–148
  49. Wong KH, Lee SS, Lim WL, Low HK. Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. Journal of Substance Abuse Treatment. 2003;24(3):233–239
  50. World Health Organization . Principles of drug dependence treatment. Geneva: WHO; 2008;

PII: S0955-3959(10)00101-5

doi: 10.1016/j.drugpo.2010.06.006

International Journal of Drug Policy
Volume 21, Issue 6 , Pages 459-465 , November 2010

Article Tools